Upcoming Event: BIOPLUS INTERPHEX Korea 2026 x KACTUS

KACTUS is excited to return to BIOPLUS INTERPHEX (BIX) Korea 2026, taking place October 28–30, 2026 at COEX in Seoul, Korea. As Korea’s leading business platform connecting the entire biopharmaceutical value chain, BIX brings together companies, researchers, and industry leaders to share technologies, build partnerships, and explore new opportunities across the global bio-pharmaceutical industry.

What is BIOPLUS INTERPHEX Korea?

BIOPLUS INTERPHEX Korea is Korea’s leading business platform connecting the full biopharmaceutical value chain. Hosted by KoreaBIO and organized by RX Korea, the event brings together companies spanning drug discovery and development, biomanufacturing, process technologies, packaging, digital innovation, and other areas shaping the future of biopharma.

Through its combination of a large-scale exhibition, conference programming, partnering opportunities, open innovation programs, and networking, BIX creates a central meeting point for companies to exchange knowledge, showcase new technologies, and build collaborations across Korea and the international biopharmaceutical community.

Event Overview 

Venue: COEX, Hall C (3F), The Platz (2F), and Conference Rooms (3F & 4F), 513 Yeongdong-daero, Gangnam-gu, Seoul, Republic of Korea

Dates: October 28–30, 2026

• Conference Day 1: Wednesday, October 28, 2026 | Show Hours: 10:00 AM–5:00 PM

• Conference Day 2: Thursday, October 29, 2026 | Show Hours: 10:00 AM–5:00 PM

• Conference Day 3: Friday, October 30, 2026 | Show Hours: 10:00 AM–5:00 PM

KACTUS Booth: G13

Event Schedule

BIOPLUS INTERPHEX Korea 2026 will feature three days of conference programming alongside the exhibition, partnering, open innovation, and networking at COEX Seoul. While the full 2026 agenda has not yet been released, BIX programming typically spans technology, regulatory, business, and industry initiative topics across the biopharmaceutical value chain. Recent programs have explored areas including drug discovery and development, ADCs and next-generation biologics, radiopharmaceuticals, global regulatory strategy, biomanufacturing, cold-chain logistics, AI and digital technologies, commercialization, licensing, and cross-border collaboration. For the latest 2026 session times, speakers, and program updates, please refer to the BIOPLUS INTERPHEX Korea Conference At a Glance.

About KACTUS

KACTUS excels in crafting and producing an array of superior-grade, highly active recombinant proteins and enzymes, catering to diverse sectors like antibody drug discovery, immunotherapy, gene therapy, and mRNA therapeutics. Our expansive catalog, boasting over 3,000 recombinant proteins, encompasses a wide spectrum of targets, species, tags, and labels, each thoughtfully chosen to address the specific, unmet needs of scientists engaged in drug development. The hallmark of our product selection process is a rigorous emphasis on exceptional quality and a steadfast commitment to ensuring reliable supply, thereby upholding the highest standards of excellence and client satisfaction.